NEWS - Sep 23, 2015 Relmada Therapeutics to Present at Ladenburg Thalmann 2015 Healthcare Conference Read more
NEWS - Sep 9, 2015 Relmada Therapeutics Announces Issuance of U.S. Patent Covering SECUREL™ - an Abuse-Deterrent, Extended-Release, Technology Platform for Opioids Read more
NEWS - Sep 2, 2015 Relmada Therapeutics to Participate in Two Upcoming Investor Conferences Read more
NEWS - Aug 17, 2015 Relmada Therapeutics Receives Health Canada Clearance to Commence Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist Read more
NEWS - Aug 12, 2015 Relmada Therapeutics Announces Launch of New Website and Corporate Communication Channels Read more
NEWS - Aug 10, 2015 Relmada Therapeutics Announces Reverse Stock Split in Preparation for Proposed Uplisting to NASDAQ Capital Market Read more
NEWS - Jul 27, 2015 Relmada Therapeutics Announces Filing of Clinical Trial Application in Canada for Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist d-Methadone Read more
NEWS - Jul 16, 2015 Relmada Therapeutics Appoints Charles J. Casamento to Its Board of Directors Read more
NEWS - Jun 29, 2015 Enrollment in Relmada Therapeutics' Proof-of-Concept Clinical Study for Novel Oral Formulations of Buprenorphine Reaches Halfway Mark Read more
